Form 8-K - Current report:
SEC Accession No. 0001193125-25-226749
Filing Date
2025-10-01
Accepted
2025-10-01 16:05:22
Documents
12
Period of Report
2025-09-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d20952d8k.htm   iXBRL 8-K 23906
  Complete submission text file 0001193125-25-226749.txt   137347

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20250926.xsd EX-101.SCH 2840
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20250926_lab.xml EX-101.LAB 17977
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20250926_pre.xml EX-101.PRE 11251
15 EXTRACTED XBRL INSTANCE DOCUMENT d20952d8k_htm.xml XML 3658
Mailing Address 919 WEST DILLON ROAD LOUISVILLE CO 80027
Business Address 919 WEST DILLON ROAD LOUISVILLE CO 80027 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

EIN.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 251364653
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)